Sclerosing cholangitis - Primary, secondary and more...

Israel Medical Association Journal

Volumn 4, Issue 12, 2002, Pages 1141-1142

  Kariv, Revital ^a   Konikoff, Fred M ^a,b  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Bile ducts; Biliary cirrhosis; Cholestasis; Endoscopic retrograde cholangiopancreatography; Sclerosing cholangitis

Indexed keywords

ALBENDAZOLE; ALBENDAZOLE SULFOXIDE; ALCOHOL; ANTHELMINTIC AGENT; ANTIBIOTIC AGENT; AUTOANTIBODY; FORMALDEHYDE; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; SCLEROSING AGENT; SODIUM CHLORIDE; STEROID; TACROLIMUS;

BILE DUCT CARCINOMA; BILE DUCT FISTULA; BILE DUCT SCLEROSIS; BILIARY CIRRHOSIS; CHOLANGITIS; CHOLELITHIASIS; CHOLESTASIS; COMORBIDITY; CONTAMINATION; CYSTECTOMY; DISEASE COURSE; DRUG EFFICACY; EDITORIAL; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENDOSCOPY; HUMAN; HYPERGAMMAGLOBULINEMIA; LIVER FAILURE; LIVER HYDATID CYST; LIVER INJURY; NONHUMAN; RECURRENT DISEASE; SCLEROSING CHOLANGITIS; SPHINCTEROTOMY; STENT; SYMPTOM;

CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; CHOLANGITIS, SCLEROSING; HUMANS; LIVER TRANSPLANTATION;

EID: 0036911312     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (25)

1. Delbet MD. Retrécissement du choladogue cholecysto-duodenostomie. Bull Mem Nation Chirurgie 1924;50:1144.
2. Lee YM, Kaplan M. Primary sclerosing cholangitis. N Engl J Med 1995;332:924-33.
3. Chapman RW, Arborgh BA, Rhodes JM, et al. Primary sclerosing cholangitis: A review of its clinical features, cholangiography and hepatic histology. Gut 1980;21:870-7.
4. Forbes A, Blanshard C, Gazzardd B. Natural history of AIDS related sclerosing cholangitis - A study of 20 cases. Gut 1993;34:116-21.
5. Chapman RW, Burroughs AK, Bass NM, et al. Long standing asymptomatic sclerosing cholangitis. Dig Dis Sci 1981;26:778-82.
6. Kaw M, Silverman WB, Rabinowitz M, et al. Biliary tract calculi in primary sclerosing cholangitis. Am J Gastroenterol 1995;90:72-5.
7. Helzberg JH, Peterson JM, Boyer JL. Improved survival with primary sclerosing cholangitis. Gastroenterology 1987;92:1869-75.
8. Belghiti J, Benhamou, JP, Houry S, et al. Caustic sclerosing cholangitis - A complication of a surgical treatment of hydatid disease of the liver. Arch Surg 1986;121:1162-5.
9. Wiesner RH. Current concepts in primary sclerosing cholangitis. Mayo Clin Proc 1994;69:969-82.
10. Boberg KM, Fausa O, Haaland T, et al. Features of autoimmune hepatitis in primary sclerosing cholangitis: An evaluation of 114 primary sclerosing cholangitis patients according to a scoring system for the diagnosis of autoimmune hepatitis. Heptology 1996;23:1369-76.
11. Lindor KD, Wiesner RH, Colwell LJ, et al. The combination of prednisone and colchicine for primary sclerosing cholangitis. Am J Gastroenterol 1991;86:57-61.
12. Chazouilliris O, Poupon R, Capron JP, et al. Ursodeoxycholic acid for primary sclerosing cholangitis. J Hepatol 1990;11:120-3.
13. Mitchell SA, Bansi DS, Hunt N, et al. A preliminary trial of high-dose ursodeoxycholic acid in primary sclerosing cholangitis. Gastroenterology 2001;121:900-7.
14. Lee JG, Schutz SM, England RE, et al. Endoscopic therapy for sclerosing cholangitis. Hepatology 1995;21:661-7.
15. Narumi S, Roberts JP, Emond JC, et al. Liver transplantation for sclerosing cholangitis. Hepatology 1995;22:451-7.
16. Morali G, Safadi R, Pappo O, Jurim O, Shouval D. Caustic sclerosing cholangitis treated with orthotopic liver transplantation. IMAJ 2002;4:1152-3.
17. Ustusoz B, Akhan O, Kamiloglu MA, et al. Percutaneous treatment of hydatid cysts of the liver: Long term results. AJR 1999;172:91-6.
18. Aktan AO, Yalin R. Preoperative albendazole treatment for liver hydatid disease decreases the viability of the cyst. Eur J Gastroenterol Hepatol 1996;8:877-9.
19. Safioleas M, Misiakos EP, Kakisis J, et al. Surgical treatment of human echinococcosis. Int Surg 2000;85:358-65.
20. Atli M, Kama NA, Yuksek YN, et al. Intrabiliary rupture of a hepatic hydatid cyst: Associated clinical factors and proper management. Arch Surg 2001;136:1249-55.
21. Giouleme O, Nikolaidis N, Zezos P, et al. Treatment of complications of hepatic hydatid disease by ERCP. Gastrointest Endosc 2001;54:508.
22. Beyrouti MI, Kharrat M, Elleuch S, et al. Internal trans-Oddi's sphincter fistula drainage of hydatid cysts communicating with the bile ducts. Presse Med 2001;30:1863-7.
23. Erzurumlu K, Ozdemir M, Mihmanli M, et al. The effect of intraoperative mebendazole-albendazole applications on the hepatobiliary system. Eur Surg Res 1995;27:340-5.
24. Deger E, Hokelek M, Deger BA, et al. A new therapeutic approach for the treatment of cystic echinococcosis: Percutaneous albendazole sulphoxide injection without reaspiration. Am J Gastroenterol 2000;95:248-54.
25. Mehal WZ, Lo YM, Woodsworth B, et al. HLA D4 is a marker for rapid disease progression in primary sclerosing cholangitis. Gastroenterology 1994;106:160-7.